Literature DB >> 6810912

Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.

C A Jackson, M Greaves, A D Patterson, C B Brown, F E Preston.   

Abstract

Increased platelet aggregability on stimulation with sodium arachidonate (NaAA), collagen and ADP was found in a group of 14 patients with nephrotic syndrome when compared with age and sex matched controls. Five of the group also exhibited spontaneous platelet aggregation (SPA), associated with synthesis of thromboxane B2 (TxB2), and which appeared to correlate with a markedly increased serum triglyceride concentration. Thromboxane B2 generation in response to NaAA was increased and reflected both the low serum albumin concentration and the platelet aggregation response to this agent. Addition of albumin in vitro decreased the amount of TxB2 generated for a given dose of NaAA and increased NaAA and collagen-induced platelet aggregation thresholds. However, albumin had no significant effect on collagen-induced TxB2 production. The results suggest that the hypoalbuminaemia and associated reduced binding of arachidonic acid and increased synthesis of TxA2 account in part for the increased platelet aggregability seen in the nephrotic syndrome but that other mechanisms are also involved.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810912     DOI: 10.1111/j.1365-2141.1982.tb03862.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Barbara Tomaszewska; Anna Biernacka
Journal:  Pediatr Nephrol       Date:  2004-10-13       Impact factor: 3.714

3.  Superior mesenteric artery thrombosis associated with antiphospholipid syndrome.

Authors:  M E Hamilton
Journal:  West J Med       Date:  1991-08

Review 4.  Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms.

Authors:  Keattiyoat Wattanakit; Mary Cushman
Journal:  Curr Opin Pulm Med       Date:  2009-09       Impact factor: 3.155

5.  In vivo platelet activity and serum albumin concentration in nephrotic syndrome.

Authors:  F Goubran; F Maklady
Journal:  Blut       Date:  1988-07

6.  Haemostatic measurements in childhood nephrotic syndrome.

Authors:  A T Elidrissy; M B Abdurrahman; H M Bahakim; M D Jones; A M Gader
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

7.  Human group II 14 kDa phospholipase A2 activates human platelets.

Authors:  J Polgár; R M Kramer; S L Um; J A Jakubowski; K J Clemetson
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

8.  Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

Authors:  D P Mikhailidis; M A Barradas; A Maris; J Y Jeremy; P Dandona
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

9.  Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

Authors:  J J Zwaginga; H A Koomans; J J Sixma; T J Rabelink
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  The platelet defect in acute myeloid leukaemia.

Authors:  B E Woodcock; P C Cooper; P R Brown; C Pickering; D A Winfield; F E Preston
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.